Please login to the form below

Not currently logged in
Email:
Password:

Abbott sues J&J over Simponi

Abbott laboratories has sued Johnson & Johnson over its drug Simponi, stating that preparations to market the drug infringe a patent issued for Humira

Abbott laboratories has sued Johnson & Johnson over its drug Simponi, stating that preparations to market the drug infringe a patent issued for Humira.

Abbott's Humira (adalimumab), which treats rheumatoid arthritis, was issued a patent in 2007. Johnson & Johnson's Centocor unit plans to introduce golimumab, a new and competing drug for the crippling disease under the brand name Simponi.

Abbott is seeking cash compensation and an order to prevent further use of its invention by Johnson & Johnson.

Scott Stoffell, Abbott's spokesperson explained: "We're not asking the court to prevent the launch of Simponi. Abbott has no plans to file for a preliminary injunction or a temporary restraining order."

In response, Brian Kenney of Johnson & Johnson's Centocor unit said: "We are currently reviewing the complaint and will vigorously contest it… We believe we have rights to all of the intellectual property we need to market Simponi."

Johnson & Johnson received approval from the Food and Drug Administration (FDA) to market the anti-TNF-alpha therapy for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in April 2009. The drug, to be co-marketed outside the US by Schering-Plough, will compete with Humira and Amgen's Enbrel.

5th May 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics